17 alpha-hydroxylase deficiency risk factors: Difference between revisions
(Created page with "__NOTOC__ {{Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency}} {{CMG}}; {{AE}} {{Ammu}} ==Overview== The most potent risk factor in the development of con...") |
Iqra Qamar (talk | contribs) |
||
| (8 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{17 alpha-hydroxylase deficiency}} | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}}, {{MJ}} | ||
==Overview== | ==Overview== | ||
The most potent risk factor | The most potent risk factor for the development of 17 alpha-hydroxylase deficiency is a positive [[family history]] of 17 alpha-hydroxylase deficiency. | ||
==Risk Factors== | ==Risk Factors== | ||
The most potent risk factor | The most potent risk factor for the development of 17 alpha-hydroxylase deficiency is a positive [[family history]] of 17 alpha-hydroxylase deficiency.<ref name="pmid28476231">{{cite journal |vauthors=Hannah-Shmouni F, Chen W, Merke DP |title=Genetics of Congenital Adrenal Hyperplasia |journal=Endocrinol. Metab. Clin. North Am. |volume=46 |issue=2 |pages=435–458 |year=2017 |pmid=28476231 |doi=10.1016/j.ecl.2017.01.008 |url=}}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 12:07, 23 October 2017
|
17 alpha-hydroxylase deficiency Microchapters |
|
Differentiating 17 alpha-hydroxylase deficiency from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
17 alpha-hydroxylase deficiency risk factors On the Web |
|
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency risk factors |
|
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2], Mehrian Jafarizade, M.D [3]
Overview
The most potent risk factor for the development of 17 alpha-hydroxylase deficiency is a positive family history of 17 alpha-hydroxylase deficiency.
Risk Factors
The most potent risk factor for the development of 17 alpha-hydroxylase deficiency is a positive family history of 17 alpha-hydroxylase deficiency.[1]
References
- ↑ Hannah-Shmouni F, Chen W, Merke DP (2017). "Genetics of Congenital Adrenal Hyperplasia". Endocrinol. Metab. Clin. North Am. 46 (2): 435–458. doi:10.1016/j.ecl.2017.01.008. PMID 28476231.